Sight Sciences, INC Form 4 insider transactions

David Badawi, Chief Technology Officer of Sight Sciences, sold 3,111 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., sold 4,864 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Sight Sciences' Chief Financial Officer, Alison Bauerlein, sold 10,102 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Sight Sciences CEO, Paul Badawi, sold 12,236 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Manohar K. Raheja, EVP of Research & Development at Sight Sciences, acquired 5,000 shares of common stock at $3.85 per share.

Manohar K. Raheja, EVP of Research & Development at Sight Sciences, acquired 3,376 shares of common stock at $3.89 per share.

Manohar K. Raheja, EVP of Research & Development at Sight Sciences, acquired 4,624 shares of common stock at an average price of $3.988.

Manohar K. Raheja, EVP of Research & Development at Sight Sciences, acquired 2,000 shares of common stock at $3.70 per share on November 19, 2024.

Staffan Encrantz, a director at Sight Sciences, engaged in a series of transactions involving the company's common stock, including a sale and purchase on November 21, 2024.

Brenton Taylor, EVP of Operations at Sight Sciences, was granted 160,000 restricted stock units (RSUs) under the company's 2021 Incentive Award Plan.

Manohar K. Raheja, EVP of Research & Development at Sight Sciences, was granted 96,000 restricted stock units (RSUs) under the company's 2021 Incentive Award Plan.

Chief Commercial Officer of Sight Sciences, Matthew Link, sold shares of common stock on October 18 and 21, 2024, to cover tax liabilities related to vesting restricted stock units.

Matthew Link, Chief Commercial Officer of Sight Sciences, sold shares of common stock to cover tax liabilities related to the vesting of restricted stock units.

Sight Sciences CEO Paul Badawi sold 12,727 shares of common stock on October 2, 2024, to cover tax liabilities related to the vesting of restricted stock units.

Jeremy Hayden, Chief Legal Officer of Sight Sciences, Inc., sold 4,878 shares of common stock on October 1, 2024, to cover tax liabilities related to vesting restricted stock units.

David Badawi, Chief Technology Officer of Sight Sciences, Inc., sold 3,167 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Alison Bauerlein, CFO of Sight Sciences, sold 10,130 shares of common stock on October 1, 2024, to cover tax liabilities related to vesting restricted stock units.

Sam Boong Park, COO of Sight Sciences, sold 3,403 shares of common stock on October 1, 2024, to cover tax liabilities related to vesting restricted stock units.

Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., sold 5,055 shares of common stock on July 2, 2024, to cover tax liabilities related to vesting restricted stock units.

David Badawi, Chief Technology Officer of Sight Sciences, sold 3,128 shares of common stock on July 1, 2024, to cover tax liabilities related to vesting restricted stock units.

Sight Sciences CEO Paul Badawi sold 12,569 shares of common stock on July 1, 2024, to cover tax liabilities related to the vesting of restricted stock units.

Sam Boong Park, COO of Sight Sciences, sold 3,525 shares of common stock on July 2, 2024, to cover tax liabilities related to vesting restricted stock units.

Alison Bauerlein, CFO of Sight Sciences, Inc., sold 10,497 shares of common stock on July 2, 2024, to cover tax liabilities related to vesting restricted stock units.

Director Tamara Fountain received 17,366 restricted stock units (RSUs) from Sight Sciences, Inc. on June 6, 2024, according to a recent SEC filing.

Director Catherine Mazzacco acquired 17,366 restricted stock units in Sight Sciences, Inc. on June 6, 2024.

Director Brenda Larsen-Becker received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, under the company's Non-Employee Director Compensation Program.

Director Donald Zurbay received a grant of 17,366 restricted stock units (RSUs) from Sight Sciences, Inc. on June 6, 2024.

Director Staffan Encrantz received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, according to a Form 4 filing.

Director Erica Rogers received 17,366 restricted stock units (RSUs) from Sight Sciences on June 6, 2024, according to a Form 4 filing.

Alison Bauerlein, CFO of Sight Sciences, sold 13,066 shares of common stock on May 17, 2024, to cover tax liabilities related to vesting restricted stock units.